FDA Drug Recalls

Recalls / Class II

Class IID-502-2013

Product

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32

Brand name
Dobutamine In Dextrose
Generic name
Dobutamine In Dextrose
Active ingredient
Dobutamine Hydrochloride
Route
Intravenous
NDCs
0409-0025, 0409-2347, 0409-2346, 0409-3724, 0409-0151, 0409-1100
FDA application
NDA020201
Affected lot / code info
Lot 11-309-KL

Why it was recalled

Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

Recalling firm

Firm
Hospira Inc.
Manufacturer
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
275 N Field Dr, N/A, Lake Forest, Illinois 60045-2579

Distribution

Quantity
44,748 bags
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2013-04-30
FDA classified
2013-06-03
Posted by FDA
2013-06-12
Terminated
2014-10-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-502-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Dobutamine In Dextrose · FDA Drug Recalls